|
C2ORF64 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.618600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.420930E-03 |
| Normal-vs-Stage2 |
6.629700E-02 |
| Normal-vs-Stage3 |
9.56009999999452E-05 |
| Normal-vs-Stage4 |
1.68991999999202E-05 |
| Stage1-vs-Stage2 |
5.336200E-01 |
| Stage1-vs-Stage3 |
8.120400E-02 |
| Stage1-vs-Stage4 |
3.152200E-02 |
| Stage2-vs-Stage3 |
1.080010E-01 |
| Stage2-vs-Stage4 |
4.098300E-02 |
| Stage3-vs-Stage4 |
4.924600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44600000000039E-05 |
| Normal-vs-AfricanAmerican |
1.943900E-02 |
| Normal-vs-Asian |
3.458100E-02 |
| Caucasian-vs-AfricanAmerican |
8.485000E-01 |
| Caucasian-vs-Asian |
1.292020E-01 |
| AfricanAmerican-vs-Asian |
4.383600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.438100E-03 |
| Normal-vs-Female |
2.225100E-04 |
| Male-vs-Female |
6.175600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.262890E-03 |
| Normal-vs-Age(41-60Yrs) |
8.824600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.798700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.109700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.478400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.234800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.581200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.532200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.670800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.964800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.700480E-02 |
| Classical-VS-Follicular |
5.358400E-04 |
| Classical-VS-Other |
1.421170E-01 |
| Classical-VS-Normal |
3.6904999999976E-05 |
| Tall-VS-Follicular |
2.12419999999769E-05 |
| Tall-VS-Other |
1.049930E-02 |
| Tall-VS-Normal |
1.73599999997442E-06 |
| Follicular-VS-Other |
9.964000E-01 |
| Follicular-VS-Normal |
6.014400E-01 |
| Other-VS-Normal |
7.872800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.124700E-03 |
| Normal-vs-N1 |
6.3287000000023E-05 |
| N0-vs-N1 |
4.071800E-02 |
|
|
